This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Practice Guideline

. 2010 May:21 Suppl 5:v116-9.

doi: 10.1093/annonc/mdq189.

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

G D'Addario¹, M Früh, M Reck, P Baumann, W Klepetko, E Felip; ESMO Guidelines Working Group

Affiliations

PMID: 20555059
DOI: 10.1093/annonc/mdq189

Free article

Practice Guideline

Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

G D'Addario et al. Ann Oncol. 2010 May.

Free article

. 2010 May:21 Suppl 5:v116-9.

doi: 10.1093/annonc/mdq189.

Authors

G D'Addario¹, M Früh, M Reck, P Baumann, W Klepetko, E Felip; ESMO Guidelines Working Group

Affiliation

¹ Onkologie Schaffhausen, Switzerland.

PMID: 20555059
DOI: 10.1093/annonc/mdq189

No abstract available

PubMed Disclaimer

Similar articles

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Peters S, Adjei AA, Gridelli C, Reck M, Kerr K, Felip E; ESMO Guidelines Working Group. Peters S, et al. Ann Oncol. 2012 Oct;23 Suppl 7:vii56-64. doi: 10.1093/annonc/mds226. Ann Oncol. 2012. PMID: 22997455 No abstract available.
ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up of non-small-cell lung cancer (NSCLC).
Felip E, Stahel RA, Pavlidis N; ESMO Guidelines Task Force. Felip E, et al. Ann Oncol. 2005;16 Suppl 1:i28-9. doi: 10.1093/annonc/mdi821. Ann Oncol. 2005. PMID: 15888743 No abstract available.
Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.
Crinò L, Weder W, van Meerbeeck J, Felip E; ESMO Guidelines Working Group. Crinò L, et al. Ann Oncol. 2010 May;21 Suppl 5:v103-15. doi: 10.1093/annonc/mdq207. Ann Oncol. 2010. PMID: 20555058 No abstract available.
Non-small-cell lung cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up.
D'Addario G, Felip E; ESMO Guidelines Working Group. D'Addario G, et al. Ann Oncol. 2009 May;20 Suppl 4:68-70. doi: 10.1093/annonc/mdp132. Ann Oncol. 2009. PMID: 19454467 Review. No abstract available.
[Bronchial cancer: the initial assessment and therapeutic principles].
Lemarié E. Lemarié E. Pneumoftiziologia. 1991 Oct-Dec;40(4):19-25. Pneumoftiziologia. 1991. PMID: 1668795 Review. French. No abstract available.

See all similar articles

Cited by

Microeconomic surplus in health care: applied economic theory in health care in four European countries.
Walzer S, Nuijten M, Wiesner C, Kaier K, Johansson PO, Oertel S. Walzer S, et al. Front Pharmacol. 2013 Feb 18;4:17. doi: 10.3389/fphar.2013.00017. eCollection 2013. Front Pharmacol. 2013. PMID: 23423475 Free PMC article.
CUL4^high Lung Adenocarcinomas Are Dependent on the CUL4-p21 Ubiquitin Signaling for Proliferation and Survival.
Wang Y, Yan F, Nasar A, Chen ZS, Altorki NK, Stiles B, Narula N, Zhou P. Wang Y, et al. Am J Pathol. 2021 Sep;191(9):1638-1650. doi: 10.1016/j.ajpath.2021.05.018. Epub 2021 Jun 11. Am J Pathol. 2021. PMID: 34119472 Free PMC article.
Development of a programmed cell death ligand-1 immunohistochemical assay validated for analysis of non-small cell lung cancer and head and neck squamous cell carcinoma.
Rebelatto MC, Midha A, Mistry A, Sabalos C, Schechter N, Li X, Jin X, Steele KE, Robbins PB, Blake-Haskins JA, Walker J. Rebelatto MC, et al. Diagn Pathol. 2016 Oct 8;11(1):95. doi: 10.1186/s13000-016-0545-8. Diagn Pathol. 2016. PMID: 27717372 Free PMC article. Clinical Trial.
Diagnostic value analysis of combined detection of Trx, CYFRA21-1 and SCCA in lung cancer.
Qu T, Zhang J, Xu N, Liu B, Li M, Liu A, Li A, Tang H. Qu T, et al. Oncol Lett. 2019 May;17(5):4293-4298. doi: 10.3892/ol.2019.10073. Epub 2019 Feb 26. Oncol Lett. 2019. PMID: 30944623 Free PMC article.
Comorbidity and survival of Danish lung cancer patients from 2000-2011: a population-based cohort study.
Deleuran T, Thomsen RW, Nørgaard M, Jacobsen JB, Rasmussen TR, Søgaard M. Deleuran T, et al. Clin Epidemiol. 2013 Nov 1;5(Suppl 1):31-8. doi: 10.2147/CLEP.S47473. eCollection 2013. Clin Epidemiol. 2013. PMID: 24227921 Free PMC article.

See all "Cited by" articles

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information